Eptifab 0.75mg/ml Infusion


Product Info

Prescription required Yes
Marketer Abbott
Active Ingredient Eptifibatide (0.75mg/ml)
Storage Store in a refrigerator (2 - 8°C). Do not freeze.
Chemical ClassAmino acids, Peptides analogues
Habit FormingNo
Therapeutic ClassBLOOD RELATED
Action ClassGlycoprotein IIb/IIIa inhibitors
User Rating5.0
User Reviews687

FAQ

Question
When will I feel better after taking Eptifab 0.75mg/ml?
Eptifab 0.75mg/ml reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Eptifab 0.75mg/ml. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.
Answer

Question
What medicines should I avoid while taking Eptifab 0.75mg/ml?
Eptifab 0.75mg/ml can interact with several medicines. Do not take any medicine without talking to your doctor.
Answer

Question
Can the use of Eptifab 0.75mg/ml increase the risk of bleeding?
Yes, Eptifab 0.75mg/ml increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.
Answer
Question
What if you forget to take Eptifab Infusion?
If you miss a dose of Eptifab 0.75mg/ml, please consult your doctor.
Answer

Eptifab 0.75mg/ml Infusion Reviews

Eptifab 0.75mg/ml is a blood thinner which prevents formation of harmful blood clots. It is used in the treatment of a heart attack and also prevents the clotting of blood in the heart during an angioplasty (procedure to improve blood flow to the heart).

Eptifab 0.75mg/ml is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.

Use of this medicine may cause low blood platelets and increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. It may also cause low blood pressure as a side effect. Your doctor will explain the benefits and risks associated with this medicine before it is administered.

This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.

How Eptifab 0.75mg/ml Infusion Works

Eptifab 0.75mg/ml is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots.

How to Use Eptifab 0.75mg/ml Infusion

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

Benefits of Eptifab 0.75mg/ml Infusion

  • In Prevention of Heart attack: It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor’s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
  • In Prevention of Blood clots: Eptifab 0.75mg/ml prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack) or other blood vessels (thrombosis).

Uses of Eptifab 0.75mg/ml Infusion

  • Prevention of Heart attack
  • Prevention of Blood clots

Eptifab 0.75mg/ml Infusion Side Effects

Item form

Safety Tips

Breast feeding  CAUTION
Eptifab 0.75mg/ml should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving  NOT RELEVANT
Not relevant, as Eptifab 0.75mg/ml is intended for use in hospitalised patients.
Kidney  CAUTION
Eptifab 0.75mg/ml should be used with caution in patients with kidney disease. Dose adjustment of Eptifab 0.75mg/ml may be needed. Please consult your doctor.Use of Eptifab 0.75mg/ml is not recommended in patients with severe kidney disease.
Pregnancy  SAFE IF PRESCRIBED
Eptifab 0.75mg/ml is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Liver  CONSULT YOUR DOCTOR
There is limited information available on the use of Eptifab 0.75mg/ml in patients with liver disease. Please consult your doctor.Use of Eptifab 0.75mg/ml is not recommended in patients with severe liver disease.
Alcohol  CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Eptifab 0.75mg/ml. Please consult your doctor.

Quick Tips

  • It is usually given by your nurse or doctor as an infusion (drip) into a vein.
  • Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).
  • It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.

References

  1. Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 355-56.
  2. Central Drugs Standard Control Organisation (CDSCO). Eptifibatide.
  3. Drugs.com. Eptifibatide Pregnancy and Breastfeeding Warnings.
  4. Eptifibatide. Ferentino, Italy: Patheon Italia S.p.A.; 1998 [revised Mar. 2013].
  5. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 485-46.
  6. Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 871.

Other Medical Preparations